Deleted No
Hibernated No
Last Checked Dec. 7, 2022

Created

Mon Dec 05 14:00:07 +0000 2022

Likes

460

Retweets

260

Source

Emplifi

View Raw Data

JSON Data

View on Twitter

Likely Available
Profile Image

NEWSMAX @NEWSMAX

Pfizer and its partner BioNTech said on Monday they have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization of their omicron-adapted COVID-19 vaccine booster for children aged 6 months through 4 years. https://t.co/xPIXrEDEFm — PolitiTweet.org

Posted Dec. 5, 2022